The association of PD-L1 expression status and the PD-1/PD-L1 inhibitor-related toxicity profile in non-small cell lung cancer

Related articles

1. PD-1/PD-L1 Expression and Predictive Value of Efficacy in HCC Patients with Anti-PD1 Therapy: A Real-World Study

   This article has 6 authors:

   1. Huili Wu
   2. Hui Liu
   3. Yang Wang
   4. Lin Sun
   5. Mei Liu
   6. Jun Lv

2. Effects of Concomitant Medications on the Therapeutic Effectiveness of PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Retrospective Cohort Study

   This article has 11 authors:

   1. Yue Shen
   2. Jie-Qi Chen
   3. Zhen Yu
   4. Zhi-Lan Lin
   5. Lei Cao
   6. Hui-Zhen Li
   7. Yue-Qin Li
   8. Ying-Cai Meng
   9. Bin Li
   10. Juan Chen
   11. Xiang-Ping Li

3. Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting

   This article has 6 authors:

   1. Damianos-Ioannis Zervanos
   2. Eleftheria Galatou
   3. Androulla N. Miliotou
   4. NIkoleta F. Theodoroula
   5. Nikolaos Grigoriadis
   6. Ioannis S. Vizirianakis